Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
517.40
Change Change %
2.30 0.45%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
516.90
Change Change %
1.95 0.38%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Barclays
N/A
26-11-2015 Buy 706.20 N/A
N/A
Closed Custom
26-11-2016

Barclays upgrades Sun Pharma to overweight

Barclays upgrades Sun Pharma to overweight from equalweight earlier. Risk reward ratio is now favorable for investors. Multiple negatives are priced into the valuation. Base case suggests a 27 per cent upside potential. Bear-case scenario implies a 18 per cent downside potential.

Top